Cite

HARVARD Citation

    Cho, B. et al. (n.d.). 1497PJNJ-61186372 (JNJ-372), an EGFR-cMET bispecific antibody, in advanced non-small cell lung cancer (NSCLC): An update on phase I results. Annals of oncology. p. . [Online]. 
  
Back to record